"Alabama Internal Medicine is a medical practice located in the Trussville Office Park just off of Gadsden Hwy (US 11). The Trussville location campus is convenient to Roebuck, Huffman, Leeds, Moody as well as other areas due to our close proximity to I-20/59, I-459 and US-11, US-75 and US-78. Our physicians and staff provide compassionate and quality healthcare services to our patients in a comfortable, easily accessible, and safe environment. We provide primary care services including preventive care, wellness encounters, as well as management of chronic conditions. We also welcome our patients to seek treatment for their minor illnesses including cough, cold, sore throat and other common conditions."

During the past decade, Alabama Internal Medicine, PC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alabama Internal Medicine, PC" #1 sponsor was "Clarus Therapeutics, Inc." with 3 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alabama Internal Medicine, PC" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center" with 1 trials as a collaborator, "PharmaNet" with 1 trials as a collaborator and "inVentiv Health Clinical" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Alabama Internal Medicine, PC" are "Male Hypogonadism" (3 trials), "Hypertension" (2 trials), "Atrial Fibrillation" (1 trials), "Atrial Flutter" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Alabama Internal Medicine, PC" in a lesser frequency.

Most popular intervention types in "Alabama Internal Medicine, PC" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Oral testosterone undecanoate" (3 trials), "Darusentan" (2 trials), "Guanfacine" (2 trials), "Darusentan Placebo" (1 trials) and "Fesoterodine 8 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alabama Internal Medicine, PC" are 5 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Alabama Internal Medicine, PC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Alabama Internal Medicine, PC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Alabama Internal Medicine, PC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".